Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

(PACB)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/30/2021 08/02/2021 08/03/2021 08/04/2021 08/05/2021 Date
32.15(c) 31.24(c) 30.21(c) 32.13(c) 35.02(c) Last
2 066 580 3 696 123 2 072 240 3 261 862 3 242 830 Volume
+1.52% -2.83% -3.30% +6.36% +8.99% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 131 M - -
Net income 2021 -228 M - -
Net cash position 2021 190 M - -
P/E ratio 2021 -31,2x
Yield 2021 -
Sales 2022 187 M - -
Net income 2022 -207 M - -
Net cash position 2022 215 M - -
P/E ratio 2022 -36,4x
Yield 2022 -
Capitalization 6 966 M 6 966 M -
EV / Sales 2021 51,6x
EV / Sales 2022 36,1x
Nbr of Employees 412
Free-Float 93,2%
More Financials
Company
Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell,... 
More about the company
Ratings of Pacific Biosciences of California, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
08/04PACIFIC BIOSCIENCES OF CALIFORNIA : Morgan Stanley Adjusts Price Target on Pacif..
MT
08/04PACIFIC BIOSCIENCES OF CALIFORNIA : Q2 Loss Widens, Revenue Grows
MT
08/03PACIFIC BIOSCIENCES OF CALIFORNIA : Announces Second Quarter 2021 Financial Resu..
PU
08/03PACIFIC BIOSCIENCES : Q2 Earnings Snapshot
AQ
08/03PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
AQ
08/03PACIFIC BIOSCIENCES OF CALIFORNIA : Announces Second Quarter 2021 Financial Resu..
AQ
08/03PACIFIC BIOSCIENCES OF CALIFORNIA : Earnings Flash (PACB) PACIFIC BIOSCIENCES OF..
MT
08/03PACIFIC BIOSCIENCES OF CALIFORNIA : Acquires Biotech Firm Circulomics for Undisc..
MT
08/03PACIFIC BIOSCIENCES OF CALIFORNIA : Acquires Circulomics – A Leading High ..
AQ
08/03Pacific Biosciences of California, Inc. acquired Circulomics, Inc.
CI
07/28PACIFIC BIOSCIENCES OF CALIFORNIA : Grants Equity Incentive Award to New Employe..
AQ
07/20PACIFIC BIOSCIENCES OF CALIFORNIA : to Acquire Omniome for $800 Million, Expands..
MT
07/20PACIFIC BIOSCIENCES OF CALIFORNIA : Signs Definitive Agreement to Acquire Omniom..
PU
07/20PACIFIC BIOSCIENCES OF CALIFORNIA, I : Entry into a Material Definitive Agreemen..
AQ
07/20INVITAE : Pacific Biosciences and Invitae Announce Intent to Expand Collaboratio..
AQ
More news
News in other languages on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
02/10SoftBank invertirá US$900 millones en Pacific Biosciences
02/10EN DIRECT DES MARCHES : Air Liquide, Société Générale, Amundi, Ubisoft, Natixis,..
2020WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
2020WALL STREET STOCK EXCHANGE : USA-Les valeurs à suivre à Wall Street (actualisé)
2015PACIFIC BIOSCIENCES OF CALIFORNIA : stellt neue, auf seiner SMRT-Technologie bas..
More news
Analyst Recommendations on PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
More recommendations
Chart PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Duration : Period :
Pacific Biosciences of California, Inc. Technical Analysis Chart | PACB | US69404D1081 | MarketScreener
Technical analysis trends PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 35,02 $
Average target price 47,00 $
Spread / Average Target 34,2%
EPS Revisions
Managers and Directors
Christian O. Henry President, Chief Executive Officer & Director
Susan G. Kim Chief Financial Officer
John F. Milligan Chairman
Stephen W. Turner Chief Technology Officer
Jonas Korlach Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.23.86%6 391
DANAHER CORPORATION37.58%218 182
THERMO FISHER SCIENTIFIC15.29%211 795
INTUITIVE SURGICAL, INC.21.12%117 665
SIEMENS HEALTHINEERS AG37.68%76 803
ILLUMINA, INC.34.71%73 672